Furthermore, it has been demonstrated that the metallopeptide αH-His2 [Pd] binds to KRAS, which is a critical step in inhibiting the MAPK kinase cascade and ultimately leading to the suppression of cancer cell proliferation. Here, KRAS is linked to cancer.